RF Safe

Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies

Chin J Cancer · 2013 · Benefit · Insufficient evidence

← Research stream
BenefitInsufficient evidencePaper 6740

The abstract reports that intrabuccal administration of 27.12 MHz RF EMF amplitude-modulated at tumor-specific frequencies resulted in long-term objective responses in patients with cancer and was not associated with significant adverse effects. It also state…

Study snapshot

PublicationChin J Cancer · 2013
Study typereview
Reported directionBenefit
Evidence ratingInsufficient

Abstract

In the past century, there have been many attempts to treat cancer with low levels of electric and magnetic fields. We have developed noninvasive biofeedback examination devices and techniques and discovered that patients with the same tumor type exhibit biofeedback responses to the same, precise frequencies. Intrabuccal administration of 27.12 MHz radiofrequency (RF) electromagnetic fields (EMF), which are amplitude-modulated at tumor-specific frequencies, results in long-term objective responses in patients with cancer and is not associated with any significant adverse effects. Intrabuccal administration allows for therapeutic delivery of very low and safe levels of EMF throughout the body as exemplified by responses observed in the femur, liver, adrenal glands, and lungs. In vitro studies have demonstrated that tumor-specific frequencies identified in patients with various forms of cancer are capable of blocking the growth of tumor cells in a tissue- and tumor-specific fashion. Current experimental evidence suggests that tumor-specific modulation frequencies regulate the expression of genes involved in migration and invasion and disrupt the mitotic spindle. This novel targeted treatment approach is emerging as an appealing therapeutic option for patients with advanced cancer given its excellent tolerability. Dissection of the molecular mechanisms accounting for the anti-cancer effects of tumor-specific modulation frequencies is likely to lead to the discovery of novel pathways in cancer.

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typereview
Effect directionbenefit
Populationpatients with cancer (advanced cancer mentioned)
Sample sizeNot supplied
ExposureRF · 27.12 MHz
Evidence strengthInsufficientConfidence: 62% · Peer reviewed: yes

Main findings

The abstract reports that intrabuccal administration of 27.12 MHz RF EMF amplitude-modulated at tumor-specific frequencies resulted in long-term objective responses in patients with cancer and was not associated with significant adverse effects. It also states that in vitro, tumor-specific frequencies identified in patients can block tumor cell growth in a tissue- and tumor-specific manner, with experimental evidence suggesting effects on gene expression and mitotic spindle disruption.

Outcomes measured

  • objective tumor response
  • adverse effects/tolerability
  • tumor cell growth inhibition (in vitro)
  • gene expression related to migration and invasion
  • mitotic spindle disruption

Limitations

  • No sample size, study design details, or quantitative effect estimates are provided in the abstract.
  • Claims include both clinical and in vitro findings without specifying methods, controls, or comparators.
  • Safety/adverse effects are described qualitatively without reporting rates or follow-up duration.
View raw extracted JSON
{
  "study_type": "review",
  "exposure": {
    "band": "RF",
    "source": "intrabuccal administration device",
    "frequency_mhz": 27.12,
    "sar_wkg": null,
    "duration": null
  },
  "population": "patients with cancer (advanced cancer mentioned)",
  "sample_size": null,
  "outcomes": [
    "objective tumor response",
    "adverse effects/tolerability",
    "tumor cell growth inhibition (in vitro)",
    "gene expression related to migration and invasion",
    "mitotic spindle disruption"
  ],
  "main_findings": "The abstract reports that intrabuccal administration of 27.12 MHz RF EMF amplitude-modulated at tumor-specific frequencies resulted in long-term objective responses in patients with cancer and was not associated with significant adverse effects. It also states that in vitro, tumor-specific frequencies identified in patients can block tumor cell growth in a tissue- and tumor-specific manner, with experimental evidence suggesting effects on gene expression and mitotic spindle disruption.",
  "effect_direction": "benefit",
  "limitations": [
    "No sample size, study design details, or quantitative effect estimates are provided in the abstract.",
    "Claims include both clinical and in vitro findings without specifying methods, controls, or comparators.",
    "Safety/adverse effects are described qualitatively without reporting rates or follow-up duration."
  ],
  "evidence_strength": "insufficient",
  "confidence": 0.62,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "radiofrequency",
    "electromagnetic fields",
    "amplitude modulation",
    "tumor-specific frequencies",
    "intrabuccal administration",
    "cancer therapy",
    "objective response",
    "in vitro",
    "gene expression",
    "mitotic spindle"
  ],
  "suggested_hubs": []
}
AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.5732/cjc.013.10177
PubMed: 24206915

Read the original paper →

Related papers

← Back to the Research Library